C. M. Robinson

Oral precursor lesions and malignant transformation--who, where, what, and when?

K. Cocks, P. Sloan, P. Thomson, 2015, The British journal of oral & maxillofacial surgery.

Predicting clinical outcome following oral potentially malignant disorder treatment - the role of adjunctive diagnostic techniques

Sarah J. Johnson, P. Sloan, P. Thomson, 2014 .

HOPX functions as a tumour suppressor in head and neck cancer

P. Murray, R. Hollows, I. Paterson, 2016, Scientific Reports.

CD56 (NCAM) expression in ameloblastomas and other odontogenic lesions

John M. Wright, P. Sloan, K. Hunter, 2010, Histopathology.

Acid phosphatase isozymes in cancer of the prostate

C. M. Robinson, A. Reif, C. A. Fish, 1973, Cancer.

Clinical Outcome Following Oral Potentially Malignant Disorder Treatment: A 100 Patient Cohort Study

P. Sloan, P. Thomson, A. Diajil, 2013, International journal of dentistry.

Orcellex brush biopsy and liquid-based cytology -assessment of a new diagnostic technique in oral potentially malignant disorder management

Sarah J. Johnson, P. Sloan, P. Thomson, 2014 .

Form and Function of the Oral Mucosa

P. Thomson, C. M. Robinson, 2013 .